Apr 29, 2021 | COVID, HHSC News, Provider News
On 04/23/2021, the FDA and CDC recommended the lift of the pause on Johnson and Johnson (Janssen) Covid-19 Vaccine use following a through safety review. Use of the Janssen COVID-19 Vaccine should be resumed in the United States.The FDA and CDC have confidence that...
Apr 27, 2021 | Electronic Visit Verification, HHSC News, Provider News
FMSA Cost Survey Due Date Extended to May 19, 2021 The HHSC Provider Finance Department has contracted with Deloitte Consulting to administer a cost survey for all Financial Management Services Agencies in Texas. These agencies provide administrative support for...
Apr 7, 2021 | COVID, HHSC News, Provider News
COVID-19 Pfizer Vaccine Administration Procedure Codes 0001A and 0002A Rate Change Effective 4/1/2021. On December 18, 2020, in accordance with the FDA’s issuance of Emergency Use Authorization for the Pfizer COVID-19 Vaccine, vaccine administration procedure codes...
Apr 6, 2021 | COVID, HHSC News, Provider News
COVID-19 Moderna Vaccine Administration Procedure Codes 0011A and 0012A Rate Change Effective 4/1/2021. On December 18, 2020, in accordance with the FDA’s issuance of Emergency Use Authorization for the Moderna COVID-19 Vaccine, vaccine administration procedure codes...
Feb 22, 2021 | Electronic Visit Verification, HHSC News, Provider News
The 180 Day & 90 Day Visit Maintenance Temporary Policy (PDF) is now on the HHS EVV webpage. The policy is effective as of Jan. 1, 2021 and: Applies to all program providers, financial management services agencies and Consumer Directed Services employers required...
